Seagen reports data from sea-cd40 in combination with other therapies in metastatic pancreatic ductal adenocarcinoma (pdac) at the american society of clinical oncology gastrointestinal cancers symposium (asco gi)

Bothell, wash.--(business wire)-- #gi22--seagen reports data from sea-cd40 in combination with other therapies in metastatic pancreatic ductal adenocarcinoma at the asco gi symposium
SGEN Ratings Summary
SGEN Quant Ranking